Advertisement
Meeting Paper SMFM Paper| Volume 217, ISSUE 3, P362.e1-362.e6, September 2017

Randomized controlled trial of intravenous acetaminophen for postcesarean delivery pain control

Published:April 25, 2017DOI:https://doi.org/10.1016/j.ajog.2017.04.030

      Background

      Cesarean delivery is a common surgery in the United States, with 1.3 million performed during 2009.
      • Martin J.A.
      • Hamilton B.E.
      • Ventura S.J.
      • Osterman M.J.
      • Wilson E.C.
      • Mathews T.
      Births: final data for 2010.
      Obstetricians must balance the growing concern with opioid abuse, dependence, and side effects with optimal postoperative pain control. Intravenous acetaminophen may represent an additional method to decrease the reliance on opioid medications and improve postoperative pain following cesarean delivery.

      Objective

      The objective of the study was to determine whether the administration of intravenous acetaminophen following routine scheduled cesarean delivery would decrease the need for narcotic medications to control postoperative pain.

      Study Design

      This was an institutional review board–approved, double-blind, placebo-controlled, randomized trial, registered on clinicaltrials.gov (number 02046382). Women scheduled to undergo cesarean delivery with regional anesthesia at term were recruited. All perioperative and postpartum care was standardized via study order sets. Study patients were given all medications in a standardized manner receiving either acetaminophen 1000 mg intravenously or 100 mL saline (placebo) every 8 hours for 48 hours for a total of 6 doses. The pharmacy prepared intravenous acetaminophen and saline in identical administration bags labeled study drug to ensure blinding. The initial dose of study drug was given within 60 minutes of skin incision. Quantity of breakthrough and scheduled analgesic medications and self-reported pain levels on the Faces Pain Scale (0–10) before and after study drug administration were collected. Patient demographics were extracted from the chart. Power calculation determined that 45 patients per arm were required to detect a 30% reduction in postcesarean narcotic requirement with 80% power and a significance level of P = .05.

      Results

      A total of 133 patients were consented for the study. Twenty-nine were excluded and 104 patients completed the study: 57 received intravenous acetaminophen and 47 received placebo. There were no differences in baseline demographic characteristics including patient age, body mass index, gravidity, parity, race, comorbidities, or number of prior cesarean deliveries. There were no differences between groups in estimated blood loss or length of stay. The total amount of oral narcotic medications consumed by patients receiving intravenous acetaminophen was significantly reduced when compared with the placebo group (47 mg vs 65 mg of oxycodone; P = .034). The total amount of ibuprofen used between groups was not different. There was no difference in pain scores between groups before and after study dose administration. There was no significant difference in narcotic side effects (nausea/emesis, respiratory depression, constipation) in either study arm.

      Conclusion

      Intravenous acetaminophen in the postoperative period following cesarean delivery resulted in a significant decrease in oral narcotic consumption for pain control.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Martin J.A.
        • Hamilton B.E.
        • Ventura S.J.
        • Osterman M.J.
        • Wilson E.C.
        • Mathews T.
        Births: final data for 2010.
        Natl Vital Stat Rep. 2012; 61: 1-72
        • Frieden T.R.
        • Houry D.
        Reducing the risks of relief—the CDC opioid-prescribing guideline.
        N Engl J Med. 2016; 374: 1501-1504
        • Bateman B.T.
        • Franklin J.M.
        • Bykov K.
        • et al.
        Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women.
        Am J Obstet Gynecol. 2016; 215: 353.e1-353.e18
        • Booth J.L.
        • Harris L.C.
        • Eisenach J.C.
        • Pan P.H.
        A randomized controlled trial comparing two multimodal analgesic techniques in patients predicted to have severe pain after cesarean delivery.
        Anesth Analg. 2016; 122: 1114-1119
        • American College of Obstetricians and Gynecologists
        Obsteric analgeisa and anesthesia. ACOG Practice bulletin no. 36.
        Obstet Gynecol. 2002; 100: 177-191
        • Rosaeg O.P.
        • Lui A.C.
        • Cicutti N.J.
        • Bragg P.R.
        • Crossan M.L.
        • Krepski B.
        Peri-operative multimodal pain therapy for caesarean section: analgesia and fitness for discharge.
        Can J Anaesth. 1997; 44: 803-809
        • Prasanna A.
        • Sharma K.
        Preincision analgesia prevents immediate incidental pain after LSCS—a randomised blinded study.
        J Anaesthesiol Clin Pharmacol. 2010; 26: 375-378
        • Tsang K.
        • Page J.
        • Mackenney P.
        Can intravenous paracetamol reduce opioid use in preoperative hip fracture patients?.
        Orthopedics. 2013; 36: 20-24
        • Tzortzopoulou A.
        • McNicol E.D.
        • Cepeda M.S.
        • Francia M.B.
        • Farhat T.
        • Schumann R.
        Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.
        Cochrane Database Syst Rev. 2011; : CD007126
        • Alhashemi J.A.
        • Alotaibi Q.A.
        • Mashaat M.S.
        • Kaid T.M.
        • Mujallid R.H.
        • Kaki A.M.
        Intravenous acetaminophen vs oral ibuprofen in combination with morphine PCIA after cesarean delivery.
        Can J Anaesth. 2006; 53: 1200-1206
        • Kilicaslan A.
        • Tuncer S.
        • Yuceaktas A.
        • Uyar M.
        • Reisli R.
        [The effects of intravenous paracetamol on postoperative analgesia and tramadol consumption in cesarean operations].
        Agri. 2010; 22: 7-12
        • Omar A.A.A.
        • Issa K.A.A.
        Intravenous paracetamol (Perfalgan) for analgesia after cesarean section: a double-blind randomized controlled study.
        Rawal Medical Journal. 2011; 36: 269-273
        • Ozmete O.
        • Bali C.
        • Cok O.Y.
        • et al.
        Preoperative paracetamol improves post-cesarean delivery pain management: a prospective, randomized, double-blind, placebo-controlled trial.
        J Clin Anesth. 2016; 33: 51-57
        • Inal M.T.
        • Celik N.S.
        • Tuncay F.S.
        I.V. paracetamol infusion is better than I.V. meperidine infusion for postoperative analgesia after caesarean section.
        Internet J Anesth. 2007; 15: 5
        • Bakhsha F.
        • Niaki A.S.
        • Jafari S.Y.
        • Yousefi Z.
        • Aryaie M.
        The effects of diclofenac suppository and intravenous acetaminophen and their combination on the severity of postoperative pain in patients undergoing spinal anaesthesia during cesarean section.
        J Clin Diagn Res. 2016; 10: UC09-UC12
        • Chauhan S.P.
        • Blackwell S.C.
        • Saade G.R.
        • Society for Maternal-Fetal Medicine Health Policy Committee
        A suggested approach for implementing CONSORT guidelines specific to obstetric research.
        Obstet Gynecol. 2013; 122: 952-956
        • Tomlinson D.
        • von Baeyer C.L.
        • Stinson J.N.
        • Sung L.
        A systematic review of faces scales for the self-report of pain intensity in children.
        Pediatrics. 2010; 126: e1168-e1198
      1. Scherer R. samplesize: sample size calculation for various t tests and Wilcoxon-test. R Package, version 0.1.8. 2012. Available at: http://CRAN.R-project.org/package=samplesize.

      2. Stevenson M, Nunes T, Sanchez J, et al. epiR: an R package for the analysis of epidemiological data. R Package, version 0.9-46. 2013;.Available at: https://cran.r-project.org/web/packages/epiR/index.html.

        • Feese C.A.
        • Johnson S.
        • Jones E.
        • Lambers D.S.
        A randomized trial comparing metallic and absorbable staples for closure of a Pfannenstiel incision for cesarean delivery.
        Am J Obstet Gynecol. 2013; 209: 556.e551-556.e555
        • Farrar J.T.
        • Berlin J.A.
        • Strom B.L.
        Clinically important changes in acute pain outcome measures: a validation study.
        J Pain Symptom Manage. 2003; 25: 406-411
        • Pickens L.A.
        • Meinke S.M.
        OFIRMEV: a recently introduced drug.
        J Pediatr Nurs. 2011; 26: 494-497
        • Groudine S.
        • Fossum S.
        Use of intravenous acetaminophen in the treatment of postoperative pain.
        J Perianesth Nurs. 2011; 26: 74-80
        • Singla N.K.
        • Parulan C.
        • Samson R.
        • et al.
        Plasma and cerebrospinal fluid pharmacokinetic parameters after single-dose administration of intravenous, oral, or rectal acetaminophen.
        Pain Pract. 2012; 12: 523-532